Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms

被引:3
|
作者
Lu, Z. [1 ]
Li, T. [2 ,3 ,4 ]
Liu, C. [1 ]
Zheng, Y. [1 ,4 ]
Song, J. [1 ]
机构
[1] Chinese Acad Med Sci, Dept Gen Surg, Dept HepatoBilio Pancreat Surg, Beijing Hosp,Natl Ctr Gerontol,Inst Geriatr Med, 1 DaHua Rd, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Natl Ctr Clin Labs, Beijing Hosp, Natl Ctr Gerontol, 1 Dahua Rd, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Inst Geriatr Med, 1 Dahua Rd, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
关键词
Pancreatic neuroendocrine neoplasm; Risk factors; Prediction model; Risk stratification; Cancer-specific survival; TUMORS; GUIDELINES; DIAGNOSIS; MANAGEMENT; CANCER;
D O I
10.1007/s40618-022-01956-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose We explored risk variables associated with cancer-specific survival (CSS) in patients with pancreatic neuroendocrine neoplasms (PNENs) and created a network dynamic nomogram model to predict patient survival time. Methods A total of 7750 patients with PNENs were included in this analysis, including 134 with functional PNENs and 7616 with nonfunctional PNENs. Clinical feature and prognosis differences between functional and nonfunctional PNENs were compared. Independent prognostic factors affecting CSS were analyzed by univariate and multifactorial Cox regression. Nomogram and web-based prognosis prediction of PNENs were developed and validated by C indices, decision curve analysis, and calibration plots. Results Patients with functional PNENs were younger at diagnosis than those with nonfunctional PNENs. Functional PNENs had better prognoses than nonfunctional PNENs (5-year survival rates: 78.55% and 71.10%, respectively). Univariate and multifactorial Cox regression analyses showed that tumor infiltration (T), nodal metastasis (N), metastasis (M), tumor site, differentiation grade, age, marital status, and surgical treatment were independent prognostic risk factors for CSS, which were included in the prognostic nomogram and web-based prognosis calculator. The calibration plots and decision curve analysis showed that the nomogram had excellent prediction and clinical practical ability. The C indices for CSS in the training and validation cohorts were 0.848 (95% CI 0.838-0.8578) and 0.823 (95% CI 0.807-0.839), respectively. We scored all patients according to the nomogram and divided patients into three different risk groups. The prognosis of the low-risk population was significantly better than those of the middle- and high-risk populations based on Kaplan-Meier survival curve. Conclusion We analyzed the clinical features of PNENs and developed a convenient and web dynamic nomogram to predict CSS.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
  • [31] Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms
    Ruitong Xu
    Bingrong Zhou
    Ping Hu
    Bingyan Xue
    Danyang Gu
    Xiaolin Li
    Qiyun Tang
    World Journal of Surgical Oncology, 19
  • [32] Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms
    Xu, Ruitong
    Zhou, Bingrong
    Hu, Ping
    Xue, Bingyan
    Gu, Danyang
    Li, Xiaolin
    Tang, Qiyun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [33] Development and Validation of a Score for Screening Suicide of Patients With Neuroendocrine Neoplasms
    Lu, Lili
    Shang, Yuru
    Zechner, Dietmar
    Mullins, Christina Susanne
    Linnebacher, Michael
    Zhang, Xianbin
    Gong, Peng
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [34] Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms
    Sun, Shenghong
    Wang, Wei
    He, Chiyi
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [35] Development and validation of a risk stratification model for immediate microvascular breast reconstruction
    Roy, Melissa
    Sebastiampillai, Stephanie
    Haykal, Siba
    Zhong, Toni
    Hofer, Stefan O. P.
    O'Neill, Anne C.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1177 - 1183
  • [36] Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors
    Meng-Xia Li
    Qi-Yong Li
    Min Xiao
    Da-Long Wan
    Xin-Hua Chen
    Lin Zhou
    Hai-Yang Xie
    Shu-Sen Zheng
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (06) : 538 - 545
  • [37] Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors
    Li, Meng-Xia
    Li, Qi-Yong
    Xiao, Min
    Wan, Da-Long
    Chen, Xin-Hua
    Zhou, Lin
    Xie, Hai-Yang
    Zheng, Shu-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (06) : 538 - 545
  • [38] Development of an AI-based prediction model for the grade of pancreatic neuroendocrine neoplasm
    Teraya, Naoki
    Yamashige, Daiki
    Komatsu, Masaaki
    Takeda, Katsuji
    Harada, Naoaki
    Takasawa, Ken
    Asada, Ken
    Kaneko, Syuzo
    Hijioka, Sususmu
    Hamamoto, Ryuji
    CANCER SCIENCE, 2025, 116 : 1028 - 1028
  • [39] INTERNATIONAL VALIDATION OF THE AMSTERDAM MODEL FOR PREDICTION OF SURVIVAL AFTER RESECTED PANCREATIC CANCER
    van Roessel, Stijn
    Strijker, Marin
    Steyerberg, Ewout W.
    Groen, Jesse V.
    Mieog, J. S.
    Busch, Olivier R.
    Halimi, Asif
    Zarantonello, Laura
    Koerkamp, B. Groot
    Wellner, Ulrich F.
    van Eijck, Casper H.
    Abu Hilal, Mohammad
    Del Chiaro, Marco
    Keck, Tobias
    Alseidi, Adnan A.
    Bassi, Claudio
    Besselink, Marc
    GASTROENTEROLOGY, 2019, 156 (06) : S1406 - S1406
  • [40] Cytology Assessment Can Predict Survival for Patients With Metastatic Pancreatic Neuroendocrine Neoplasms
    Sigel, Carlie S.
    Guo, Huimin
    Sigel, Keith M.
    Zhang, Ming
    Rekhtman, Natasha
    Lin, Oscar
    Klimstra, David S.
    Jungbluth, Achim A.
    Tang, Laura K.
    CANCER CYTOPATHOLOGY, 2017, 125 (03) : 188 - 196